$42.43 0.65 (+1.56%)
2/13/2012 10:09 AM

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Featured Broker Partners


Advertisement